Alternate TextTo enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.

dCeMM2

  Cat. No.:  DC50183   Featured
Chemical Structure
296771-07-8
For research use only. We do not sell to patients.
We match the best price and quality on market.
Email:order@dcchemicals.com  sales@dcchemicals.com
Tel:+86 21 58447131
We are official vendor of:
  • 20
  • 19
  • 18
  • 17
  • 16
  • 15
  • 14
  • 12
  • 11
  • 10
  • 9
  • 8
  • 13
  • 6
  • 5
  • 4
  • 3
  • 2
  • 1
More than 5000 active chemicals with high quality for research!
Field of application
dCeMM2 (Compound 2) is a molecular glue degrader that drives the ubiquitination and degradation of cyclin K. It achieves this by facilitating an interaction between the CDK12-cyclin K complex and the CRL4B ligase complex.
Cas No.: 296771-07-8
Chemical Name: dCeMM2
Synonyms:
N-(5-chloro-2-pyridinyl)-2-(5H-[1,2,4]triazino[5,6-b]indol-3-ylthio)acetami de;dCeMM2;CCG-292043;G65270;SR-01000513440-1;STK119616;HY-144971;GLXC-26690;296771-07-8;Oprea1_440030;SR-01000513440;Oprea1_483940;N-(5-chloropyridin-2-yl)-2-(5H-[1,2,4]triazino[5,6-b]indol-3-ylsulfanyl)acetamide;SCHEMBL23257538;N-(5-chloro-2-pyridinyl)-2-(5H-[1,2,4]triazino[5,6-b]indol-3-ylsulfanyl)acetamide;AG-205/11957519;N-(5-Chloro-2-pyridinyl)-2-(5H-1,2,4-triazino[5,6-b]indol-3-ylthio)acetamide;2-((5H-[1,2,4]triazino[5,6-b]indol-3-yl)thio)-N-(5-chloropyridin-2-yl)acetamide;CS-0436568;2-(5H-[1,2,4]Triazino[5,6-b]indol-3-ylthio)-N-(5-chloropyridin-2-yl)acetamide;CeMMEC10;AKOS000713842;N-(5-CHLOROPYRIDIN-2-YL)-2-{5H-[1,2,4]TRIAZINO[5,6-B]INDOL-3-YLSULFANYL}ACETAMIDE;MS-25966
SMILES: C1=CC=C2C(=C1)C3=C(N2)N=C(N=N3)SCC(=O)NC4=NC=C(C=C4)Cl
Formula: C16H11N6Oscl
M.Wt: 370.816
Purity: >98%
Sotrage: 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO
Cat. No. Product name Field of application
DC60948 NEK7 degrader (Compound 17) NEK7 degrader-1 is a NEK7 molecular glue degrader with a DC50 of 9  nM. NEK7 degrader-1 dose-dependently inhibits caspase-1 activity and IL-Ιβ release in macrophages in response to NLRP3 inflammasome activation. NEK7 degrader-1 can be used for autoinflammatory and autoimmune disorders like multiple sclerosis, neurodegeneraive diseases like Alzheimer's disease and cardiovascular and melabolic disorders like pericarditis and Type 2 diabetes research.
DC68076 BG-BRD4-P07
DC68075 BRU-SHP2-P06
DC68074 LLY-ESR1-P05
DC68073 AST-AR-P04
DC68072 NOV-EP001
DC68071 JHU-MDM2-P03
DC68070 CAS-FAK-P02
DC68069 MDA-S24-P01
DC68068 TB-008
X